RELT
Tumor necrosis factor receptor superfamily member 19L
Also known as: FLJ14993, TNFRSF19L, TR19L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969Z4
- Gene
- RELT
- Ensembl
- ENSG00000054967
- Chromosome
- 11
- Canonical length
- 430 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is especially abundant in hematologic tissues. It has been shown to activate the NF-kappaB pathway and selectively bind TNF receptor-associated factor 1 (TRAF1). This receptor is capable of stimulating T-cell proliferation in the presence of CD3 signaling, which suggests its regulatory role in immune response. Two alternatively spliced transcript variants of this gene encoding the same protein have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
430 residues, UniProt reviewed canonical sequence.
>Q969Z4|RELT
1 MKPSLLCRPL SCFLMLLPWP LATLTSTTLW QCPPGEEPDL DPGQGTLCRP CPPGTFSAAW
61 GSSPCQPHAR CSLWRRLEAQ VGMATRDTLC GDCWPGWFGP WGVPRVPCQP CSWAPLGTHG
121 CDEWGRRARR GVEVAAGASS GGETRQPGNG TRAGGPEETA AQYAVIAIVP VFCLMGLLGI
181 LVCNLLKRKG YHCTAHKEVG PGPGGGGSGI NPAYRTEDAN EDTIGVLVRL ITEKKENAAA
241 LEELLKEYHS KQLVQTSHRP VSKLPPAPPN VPHICPHRHH LHTVQGLASL SGPCCSRCSQ
301 KKWPEVLLSP EAVAATTPVP SLLPNPTRVP KAGAKAGRQG EITILSVGRF RVARIPEQRT
361 SSMVSEVKTI TEAGPSWGDL PDSPQPGLPP EQQALLGSGG SRTKWLKPPA ENKAEENRYV
421 VRLSESNLVILocalizationUniProt · AlphaFold · HPA
Whether an antibody against RELT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 146 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 146 nTPM
- skeletal muscle: 23 nTPM
- spleen: 20 nTPM
- appendix: 12 nTPM
- lymph node: 11 nTPM
- lung: 11 nTPM
Single-cell type
- neutrophils: 145 nCPM
- pdcs: 89 nCPM
- monocytes: 86 nCPM
- cdc: 69 nCPM
- macrophages: 47 nCPM
- monocyte progenitors: 46 nCPM
Immune cell
- non-classical monocyte: 35 nTPM
- intermediate monocyte: 25 nTPM
- eosinophil: 22 nTPM
- neutrophil: 20 nTPM
- classical monocyte: 13 nTPM
- myeloid DC: 12 nTPM
Brain region
- white matter: 32 nTPM
- medulla oblongata: 26 nTPM
- pons: 24 nTPM
- cerebral cortex: 23 nTPM
- spinal cord: 22 nTPM
- hypothalamus: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RELT.
Disease | AllUniProt
Conditions RELT is implicated in, by any mechanism.
- Amelogenesis imperfecta 3C (AI3C) MIM:618386
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 104 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Amelogenesis imperfecta, type 3C
- Amelogenesis imperfecta
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNF receptor family, RELT
- Tumour necrosis factor receptor superfamily member 19
- Tumour necrosis factor receptor 19-like
- Tumor necrosis factor receptor 19-like, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RELT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RELT as an antibody target. Whether an autoantibody or antibody against RELT could matter depends on whether native RELT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RELT is annotated at the cell surface, where native RELT is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RELT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...